Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$963M |
| 3 |
Wells Fargo
WFC
|
+$647M |
| 4 |
ConocoPhillips
COP
|
+$632M |
| 5 |
UnitedHealth
UNH
|
+$490M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$907M |
| 3 |
KKR & Co
KKR
|
+$906M |
| 4 |
CRH
CRH
|
+$670M |
| 5 |
Meta Platforms (Facebook)
META
|
+$593M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.49% |
| 2 | Technology | 10.44% |
| 3 | Healthcare | 8.01% |
| 4 | Financials | 6.79% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
PUT
STMicroelectronics
STM
$44B
| $1.52M | ﹤0.01% |
38,600
-21,200
| -35% | -$881K |
|
3652
PUT
Structure Therapeutics
GPCR
$3.38B
| $1.52M | ﹤0.01% |
+38,600
| New | +$1.59M |
|
|
BLDP
3653
Ballard Power Systems
BLDP
$678M
| $1.51M | ﹤0.01% |
671,655
+436,266
| +185% | +$1.24M |
|
3654
Lantronix
LTRX
$251M
| $1.51M | ﹤0.01% |
425,781
-104,074
| -20% | -$373K |
|
3655
Hawkins
HWKN
$2.51B
| $1.51M | ﹤0.01% |
16,575
+2,625
| +19% | +$215K |
|
3656
Danaos Corp
DAC
$2.74B
| $1.5M | ﹤0.01% |
16,254
-58,312
| -78% | -$4.86M |
|
3657
Beyond Meat
BYND
$238M
| $1.5M | ﹤0.01% |
7,456
+4,569
| +158% | +$973K |
|
|
SRG
3658
Seritage Growth Properties
SRG
$119M
| $1.5M | ﹤0.01% |
320,582
-257,112
| -45% | -$1.87M |
|
|
AMED
3659
PUT
DELISTED
Amedisys
AMED
| $1.5M | ﹤0.01% |
16,300
| – | – |
|
3660
Bluerock Homes Trust
BHM
$35.4M
| $1.49M | ﹤0.01% |
85,314
-7,409
| -8% | -$126K |
|
3661
DXP Enterprises
DXPE
$2.88B
| $1.49M | ﹤0.01% |
32,544
-70,041
| -68% | -$3.54M |
|
3662
Protolabs
PRLB
$1.91B
| $1.49M | ﹤0.01% |
48,263
-517
| -1% | -$16.4K |
|
3663
PUT
Lyft
LYFT
$6.7B
| $1.49M | ﹤0.01% |
105,700
+10,900
| +11% | +$177K |
|
|
GRSD
3664
Grandstand Ltd
GRSD
$66.2M
| $1.49M | ﹤0.01% |
181,068
-183,895
| -50% | -$1.55M |
|
3665
Brookfield Asset Management
BAM
$83.2B
| $1.49M | ﹤0.01% |
+39,090
| New | +$1.54M |
|
|
ELP
3666
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $1.49M | ﹤0.01% |
222,024
+110,802
| +100% | +$798K |
|
3667
American Express Global Business Travel
GBTG
$4.95B
| $1.48M | ﹤0.01% |
+223,678
| New | +$1.37M |
|
3668
Cushman & Wakefield Ltd
CWK
$3.31B
| $1.47M | ﹤0.01% |
141,819
-649,389
| -82% | -$6.71M |
|
3669
CALL
Macy's
M
$5.79B
| $1.47M | ﹤0.01% |
76,800
-293,400
| -79% | -$5.6M |
|
3670
Fate Therapeutics
FATE
$291M
| $1.47M | ﹤0.01% |
+446,668
| New | +$1.96M |
|
3671
CALL
Robinhood
HOOD
$93.7B
| $1.46M | ﹤0.01% |
64,500
+18,200
| +39% | +$356K |
|
3672
CALL
EQT Corp
EQT
$34.1B
| $1.46M | ﹤0.01% |
39,600
-27,100
| -41% | -$1.06M |
|
3673
XPEL
XPEL
$1.37B
| $1.46M | ﹤0.01% |
41,087
+24,496
| +148% | +$1.06M |
|
3674
Hayward Holdings
HAYW
$3B
| $1.46M | ﹤0.01% |
118,651
+104,147
| +718% | +$1.45M |
|
3675
CALL
Revolution Medicines
RVMD
$44.6B
| $1.46M | ﹤0.01% |
37,600
-92,400
| -71% | -$3.45M |
|
Similar funds
Israel Englander's Q2 2024 Portfolio in Review
As of Q2 2024, Israel Englander held 6,803 positions worth $216B, down 7.8% from $234B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Israel Englander's Q2 2024 filing shows 661 new, 2,109 increased, 2,549 reduced and 995 closed positions. Its largest new stake was QXO Inc: 2,219,158 shares worth $20.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $963M.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2024 buy was QXO Inc: 2,219,158 shares worth $20.6M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $1.12B increase.
- Israel Englander's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $963M.
- Israel Englander fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $907M.
- Israel Englander's ten largest holdings make up 16% of its $216B portfolio in Q2 2024.
- Israel Englander opened 661 new positions and closed 995 in Q2 2024.
- Israel Englander's portfolio value fell 7.8% quarter-over-quarter to $216B.
Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.